Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Future Oncology (London, England)|February 10, 2016
Translational and clinical research highlights from the 38th San Antonio Breast Cancer SymposiumCaterina Fontanella, Fabio PuglisiBreast (Edinburgh, Scotland)|October 1, 2013
Selecting the neoadjuvant treatment by molecular subtype: how to maximize the benefit?Gunter von Minckwitz, Caterina FontanellaJournal of the National Cancer Institute. Monographs|June 12, 2015
Comprehensive Review on the Surrogate Endpoints of Efficacy Proposed or Hypothesized in the Scientific Community TodayGunter von Minckwitz, Caterina FontanellaBreast (Edinburgh, Scotland)|August 18, 2015
Clinical usefulness and relevance of intermediate endpoints for cytotoxic neoadjuvant therapyCaterina Fontanella, Sibylle Loibl, Gunter von MinckwitzBreast Care (Basel, Switzerland)|November 19, 2014
Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropeniaCaterina Fontanella, Silvia Bolzonello, Bianca Lederer, et al.Critical Reviews in Oncology/Hematology|December 26, 2012
Bevacizumab in older patients with advanced colorectal or breast cancerGiuseppe Aprile, Laura Ferrari, Caterina Fontanella, et al.Oncotargets and Therapy|November 8, 2014
Ramucirumab: preclinical research and clinical developmentGiuseppe Aprile, Erika Rijavec, Caterina Fontanella, et al.Clinical & Experimental Metastasis|September 8, 2015
Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategyCaterina Fontanella, Valentina Fanotto, Karim Rihawi, et al.Critical Reviews in Oncology/Hematology|May 15, 2012
Brain metastases from gastrointestinal tumours: tailoring the approach to maximize the outcomeJessica Menis, Caterina Fontanella, Alessandro Follador, et al.Expert Review of Clinical Pharmacology|January 20, 2015
Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?Claudia Bozza, Caterina Fontanella, Vanessa Buoro, et al.Pageof 4